Submit Deal

Announced

2 Dec 2022

Completed

2 Dec 2022

Bridgepoint completed the acquisition of Laboratoires Vivacy for $940m.

Synopsis

Bridgepoint, a private investment company, completed the acquisition of Laboratoires Vivacy, a medical devices provider, for $940m.

Principals

target

Laboratoires Vivacy

bidder

Bridgepoint Group

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (1)

michel cheron

CEO at LABORATOIRES VIVACY

Manager

target

Deal

£ 774 M

Total Value

Bidder Team (2)

william jackson

Managing Partner at BRIDGEPOINT GROUP

Investor

bidder

Deals

£ 5.66 B

Total Value

laurent bensaid

Partner at King & Spalding

Lawyer

bidder

Deals

£ 5.76 B

Total Value

Vendor Team (3)

laurent baril

Managing Director at Rothschild & Co

Financial Advisor

vendor

Deals

£ 27.27 B

Total Value

robert rozemulder

Managing Director at Rothschild & Co

Financial Advisor

vendor

Deals

£ 25.17 B

Total Value

gaetan gianasso

Partner at Latham & Watkins

Lawyer

vendor

Deals

£ 18.45 B

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy